Bridgewater, NJ, United States of America

Aleksandra Weichsel

This inventor holds 1 USPTO granted patent. Top assignee: Genzyme Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aleksandra Weichsel. Retrieved from https://idiyas.com/inventor/aleksandra-weichsel-ls4js20t

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Aleksandra Weichsel

Introduction

Aleksandra Weichsel is a notable inventor based in Bridgewater, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address critical health issues. Her work focuses on innovative solutions for diseases mediated by deficient CFTR activity, such as cystic fibrosis.

Latest Patents

Aleksandra holds 1 patent for her invention titled "Arylamides and methods of use thereof." This patent relates to substituted aryl amide compounds, which are designed to be pharmaceutically acceptable salts and pharmaceutical preparations. The invention outlines compositions and methods for treating diseases associated with deficient CFTR activity, highlighting its potential impact on cystic fibrosis treatment.

Career Highlights

Aleksandra is currently associated with Genzyme Corporation, where she continues to advance her research and development efforts. Her work at Genzyme has allowed her to collaborate with other experts in the field, further enhancing the impact of her innovations.

Collaborations

[Section skipped due to space constraints.]

Conclusion

Aleksandra Weichsel's contributions to pharmaceutical innovations demonstrate her commitment to improving health outcomes for patients with cystic fibrosis. Her work exemplifies the vital role of inventors in advancing medical science and technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…